SCHEMBL25329233

SCHEMBL25329233

CCOc1c(C)cc(O)c(CC)c1CC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.43
GAA P10253 4/20 0.43
HPGD P15428 3/20 0.43
ALDH1A1 P00352 3/20 0.43
KDM4E B2RXH2 3/20 0.43
HSD17B10 Q99714 3/20 0.43
GLA P06280 1/20 0.43
ESR1 P03372 4/20 0.37
AR P10275 2/20 0.33
ESR2 Q92731 2/20 0.33
MAPK1 P28482 2/20 0.33
NPSR1 Q6W5P4 2/20 0.33
HTT P42858 2/20 0.33
TSHR P16473 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
TUBB1 Q9H4B7 1/20 0.33
CYP3A4 P08684 3/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25329779 0.87 HPGD (0.42) MAPTGAAHPGDALDH1A1KDM4E
SCHEMBL25329103 0.87 ALDH1A1 (0.42) MAPTGAAHPGDALDH1A1KDM4E
SCHEMBL25329825 0.85 PTGS1 (0.36) MAPTGAAHPGDALDH1A1KDM4E
SCHEMBL25328687 0.84 NPSR1 (0.42) MAPTHPGDALDH1A1KDM4EESR1
SCHEMBL25330751 0.82 TDP1 (0.40) MAPTHPGDALDH1A1MAPK1NPSR1
SCHEMBL25329831 0.82 SCN5A (0.37) MAPTGAAHPGDALDH1A1KDM4E
SCHEMBL15562592 0.81 ALOX15 (0.37) MAPTGAAHPGDALDH1A1KDM4E
SCHEMBL25331290 0.78 NPC1 (0.32) HPGDALDH1A1MAPK1NPSR1HTT
SCHEMBL25329927 0.78 TP53 (0.32) HPGDALDH1A1ESR1ARESR2
SCHEMBL25328991 0.76 ALDH1A1 (0.45) MAPTGAAHPGDALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12583813-B2 Polymerization inhibitors BASF SE (DE) 2026-03-24 US disclosed
US-20230242472-A1 POLYMERIZATION INHIBITORS BASF SE (DE) 2023-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242472-A1 POLYMERIZATION INHIBITORS RCE1, CABLES1, DPYD MAPT 1359/4885GAA 180/4885HPGD 282/4885
US-12583813-B2 Polymerization inhibitors PTGS1, PTGER1, POT1 MAPT 2405/4885GAA 3196/4885HPGD 67/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.